Could a Pre-Chemo 'Priming' drug boost leukemia survival in kids?

NCT ID NCT03164057

First seen Jan 28, 2026 · Last updated Jun 10, 2026 · Updated 19 times

Summary

This study tests whether giving a drug that changes how DNA is read (called a DNA methyltransferase inhibitor) before standard chemotherapy can help children with newly diagnosed acute myeloid leukemia. About 206 participants will receive either azacitidine or decitabine for five days before their chemo blocks. Researchers will check if this approach is safe and if it reduces the chance of the cancer coming back.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Children's Hospital of Central California

    Madera, California, 93636, United States

  • Children's Hospital of Michigan

    Detroit, Michigan, 48201, United States

  • Children's Hospital of Orange County

    Orange, California, 92968, United States

  • Cook Children's Medical Center

    Fort Worth, Texas, 76104, United States

  • Dana-Farber Cancer Institute

    Boston, Massachusetts, 02215, United States

  • Lucile Packard Children's Hospital Stanford University

    Palo Alto, California, 94304, United States

  • Rady Children's Hospital and Health Center

    San Diego, California, 92123, United States

  • Sanford Children's Specialty Clinic

    Sioux Falls, South Dakota, 57117, United States

  • St. Jude Children's Research Hospital

    Memphis, Tennessee, 38105, United States

  • University of Chicago Children's Hospital (Comer)

    Chicago, Illinois, 60637, United States

Conditions

Explore the condition pages connected to this study.